“PCD has different mucosal cell responses compared with idiopathic perianal fistulas or CD without perianal disease,” explained Dr Siyan Cao (Washington University in St Louis, MO, USA). “And some of these pathogenic pathways may become therapeutic targets for perianal CD.”
The current study collected biopsies from the rectum, fistula tracts, and fistula openings of patients with perianal CD, idiopathic fistulas, and CD without perianal disease. The investigators performed single-cell RNA sequencing to examine the pathogenesis of perianal CD and identify potential therapeutic targets for this disease.
The main findings of the study included that:
- perianal CD was associated with enhanced IFN-γ and TNF-α responses in fistula tracts and luminal mucosa of the rectum, colon, and terminal ileum;
- rectal epithelial cells expressed elevated IFN-γ responsive genes in active perianal CD;
- increased IFN-γ and TNF-α response may drive epithelial-mesenchymal transitioning in perianal CD;
- T-helper 17 cells expressed heightened IFN-γ in perianal CD fistulas; and
- immunohistochemistry showed upregulated IFN-γ and p-STAT1 in perianal CD fistula tracts.
“We are currently working to expand our research and think about testing IFN-γ antagonists in animal models of perianal CD,” Dr Cao concluded.
- Cao S, et al. Pathogenesis and therapeutic targets of perianal fistulizing Crohn’s disease by multi-omics analysis. LB08, UEG Week 2024, 12–15 October, Vienna, Austria.
Medical writing support was provided by Robert van den Heuvel.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement Next Article
Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA »
« The current state of digital pathology, molecular diagnostics and biobanking in renal cancer: Kidney Cancer Association Consensus Statement Next Article
Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA »
Table of Contents: UEGW 2024
Featured articles
Tamuzimod delivers promising long-term data in ulcerative colitis
CULTIVATE: Good signal for etrasimod in Crohn’s disease
Online First
Upadacitinib associated with normalisation of HRQoL in UC
Diagnostic accuracy of fluorescence confocal laser microscopy after EUS-TA
New insights into perianal fistulising CD pathogenesis may lead to new therapeutics
TL1A inhibitor tulisokibart shows potential in ulcerative colitis
An accelerated treatment approach may save lives in pancreatic walled-off necrosis
Encouraging results for L-carnitine in non-alcoholic fatty liver disease
LOVE-CD: Vedolizumab yields better outcomes in early than in late CD
Tamuzimod delivers promising long-term data in ulcerative colitis
Cendakimab meets primary endpoints in eosinophilic oesophagitis
How useful is colonoscopy for constipation in young women?
Guar gum alleviates IBS-related constipation in randomised-controlled trial
CULTIVATE: Good signal for etrasimod in Crohn’s disease
Meaningful corticosteroid-sparing effect of mirikizumab in UC
Is FMT a viable option to treat primary C. difficile infections?
Extending ustekinumab dosing interval does not influence drug survival in IBD
TACITO: Does FMT improve ICI plus VEGFR TKI therapy in mRCC?
Related Articles
May 21, 2019
Renal cell carcinoma
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com